NEW YORK, Oct. 14, 2019 /PRNewswire/ --
Monoclonal Antibodies market worldwide is projected to grow by US$47.6 Billion, driven by a compounded growth of 6%. Inflammatory Disease, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$44.3 Billion by the year 2025, Inflammatory Disease will bring in healthy gains adding significant momentum to global growth.
Download the full report: https://www.reportbuyer.com/product/5817883/?utm_source=PRN
- Representing the developed world, the United States will maintain a 5.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.7 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.5 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Inflammatory Disease will reach a market size of US$2.1 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 8.9% over the next couple of years and add approximately US$12.9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
- Competitors identified in this market include among others, Abbott Diagnostics, Inc. - Core Laboratory; AbbVie, Inc.; Amgen, Inc.; AstraZeneca PLC; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche AG; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG
Download the full report: https://www.reportbuyer.com/product/5817883/?utm_source=PRN
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Monoclonal Antibodies Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Monoclonal Antibodies Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Monoclonal Antibodies Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Monoclonal Antibodies Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Inflammatory Disease (Indication) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Inflammatory Disease (Indication) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 6: Inflammatory Disease (Indication) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 7: Cancer (Indication) Potential Growth Markets Worldwide
in US$ Million: 2018 to 2025
Table 8: Cancer (Indication) Historic Market Perspective by
Region/Country in US$ Million: 2009 to 2017
Table 9: Cancer (Indication) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Microbial Disease (Indication) Geographic Market
Spread Worldwide in US$ Million: 2018 to 2025
Table 11: Microbial Disease (Indication) Region Wise Breakdown
of Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Microbial Disease (Indication) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Other Indications (Indication) World Market Estimates
and Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Other Indications (Indication) Market Historic Review
by Region/Country in US$ Million: 2009 to 2017
Table 15: Other Indications (Indication) Market Share Breakdown
by Region/Country: 2009 VS 2019 VS 2025
Table 16: Humanized (Source) World Market by Region/Country in
US$ Million: 2018 to 2025
Table 17: Humanized (Source) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 18: Humanized (Source) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Human (Source) World Market Estimates and Forecasts
in US$ Million by Region/Country: 2018 to 2025
Table 20: Human (Source) Market Worldwide Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 21: Human (Source) Market Percentage Share Distribution
by Region/Country: 2009 VS 2019 VS 2025
Table 22: Chimeric (Source) Market Opportunity Analysis
Worldwide in US$ Million by Region/Country: 2018 to 2025
Table 23: Chimeric (Source) Global Historic Demand in US$
Million by Region/Country: 2009 to 2017
Table 24: Chimeric (Source) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 25: Murine (Source) World Market by Region/Country in US$
Million: 2018 to 2025
Table 26: Murine (Source) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 27: Murine (Source) Market Share Breakdown of Worldwide
Sales by Region/Country: 2009 VS 2019 VS 2025
Table 28: Diagnostic (Application) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2018-2025
Table 29: Diagnostic (Application) Retrospective Demand
Analysis in US$ Million by Region/Country: 2009-2017
Table 30: Diagnostic (Application) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 31: Therapeutic (Application) Demand Potential Worldwide
in US$ Million by Region/Country: 2018-2025
Table 32: Therapeutic (Application) Historic Sales Analysis in
US$ Million by Region/Country: 2009-2017
Table 33: Therapeutic (Application) Share Breakdown Review by
Region/Country: 2009 VS 2019 VS 2025
Table 34: Other Applications (Application) Worldwide Latent
Demand Forecasts in US$ Million by Region/Country: 2018-2025
Table 35: Other Applications (Application) Global Historic
Analysis in US$ Million by Region/Country: 2009-2017
Table 36: Other Applications (Application) Distribution of
Global Sales by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Monoclonal Antibodies Market Share (in %) by Company: 2019 &
2025
Table 37: United States Monoclonal Antibodies Market Estimates
and Projections in US$ Million by Indication: 2018 to 2025
Table 38: Monoclonal Antibodies Market in the United States by
Indication: A Historic Review in US$ Million for 2009-2017
Table 39: United States Monoclonal Antibodies Market Share
Breakdown by Indication: 2009 VS 2019 VS 2025
Table 40: United States Monoclonal Antibodies Market Estimates
and Projections in US$ Million by Source: 2018 to 2025
Table 41: Monoclonal Antibodies Market in the United States by
Source: A Historic Review in US$ Million for 2009-2017
Table 42: United States Monoclonal Antibodies Market Share
Breakdown by Source: 2009 VS 2019 VS 2025
Table 43: United States Monoclonal Antibodies Latent Demand
Forecasts in US$ Million by Application: 2018 to 2025
Table 44: Monoclonal Antibodies Historic Demand Patterns in the
United States by Application in US$ Million for 2009-2017
Table 45: Monoclonal Antibodies Market Share Breakdown in the
United States by Application: 2009 VS 2019 VS 2025
CANADA
Table 46: Canadian Monoclonal Antibodies Market Estimates and
Forecasts in US$ Million by Indication: 2018 to 2025
Table 47: Canadian Monoclonal Antibodies Historic Market Review
by Indication in US$ Million: 2009-2017
Table 48: Monoclonal Antibodies Market in Canada: Percentage
Share Breakdown of Sales by Indication for 2009, 2019, and 2025
Table 49: Canadian Monoclonal Antibodies Market Estimates and
Forecasts in US$ Million by Source: 2018 to 2025
Table 50: Canadian Monoclonal Antibodies Historic Market Review
by Source in US$ Million: 2009-2017
Table 51: Monoclonal Antibodies Market in Canada: Percentage
Share Breakdown of Sales by Source for 2009, 2019, and 2025
Table 52: Canadian Monoclonal Antibodies Market Quantitative
Demand Analysis in US$ Million by Application: 2018 to 2025
Table 53: Monoclonal Antibodies Market in Canada: Summarization
of Historic Demand Patterns in US$ Million by Application for
2009-2017
Table 54: Canadian Monoclonal Antibodies Market Share Analysis
by Application: 2009 VS 2019 VS 2025
JAPAN
Table 55: Japanese Market for Monoclonal Antibodies: Annual
Sales Estimates and Projections in US$ Million by Indication
for the Period 2018-2025
Table 56: Monoclonal Antibodies Market in Japan: Historic Sales
Analysis in US$ Million by Indication for the Period 2009-2017
Table 57: Japanese Monoclonal Antibodies Market Share Analysis
by Indication: 2009 VS 2019 VS 2025
Table 58: Japanese Market for Monoclonal Antibodies: Annual
Sales Estimates and Projections in US$ Million by Source for
the Period 2018-2025
Table 59: Monoclonal Antibodies Market in Japan: Historic Sales
Analysis in US$ Million by Source for the Period 2009-2017
Table 60: Japanese Monoclonal Antibodies Market Share Analysis
by Source: 2009 VS 2019 VS 2025
Table 61: Japanese Demand Estimates and Forecasts for
Monoclonal Antibodies in US$ Million by Application: 2018 to
2025
Table 62: Japanese Monoclonal Antibodies Market in US$ Million
by Application: 2009-2017
Table 63: Monoclonal Antibodies Market Share Shift in Japan by
Application: 2009 VS 2019 VS 2025
CHINA
Table 64: Chinese Monoclonal Antibodies Market Growth Prospects
in US$ Million by Indication for the Period 2018-2025
Table 65: Monoclonal Antibodies Historic Market Analysis in
China in US$ Million by Indication: 2009-2017
Table 66: Chinese Monoclonal Antibodies Market by Indication:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 67: Chinese Monoclonal Antibodies Market Growth Prospects
in US$ Million by Source for the Period 2018-2025
Table 68: Monoclonal Antibodies Historic Market Analysis in
China in US$ Million by Source: 2009-2017
Table 69: Chinese Monoclonal Antibodies Market by Source:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 70: Chinese Demand for Monoclonal Antibodies in US$
Million by Application: 2018 to 2025
Table 71: Monoclonal Antibodies Market Review in China in US$
Million by Application: 2009-2017
Table 72: Chinese Monoclonal Antibodies Market Share Breakdown
by Application: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Monoclonal Antibodies Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 73: European Monoclonal Antibodies Market Demand Scenario
in US$ Million by Region/Country: 2018-2025
Table 74: Monoclonal Antibodies Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 75: European Monoclonal Antibodies Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 76: European Monoclonal Antibodies Market Estimates and
Forecasts in US$ Million by Indication: 2018-2025
Table 77: Monoclonal Antibodies Market in Europe in US$ Million
by Indication: A Historic Review for the Period 2009-2017
Table 78: European Monoclonal Antibodies Market Share Breakdown
by Indication: 2009 VS 2019 VS 2025
Table 79: European Monoclonal Antibodies Market Estimates and
Forecasts in US$ Million by Source: 2018-2025
Table 80: Monoclonal Antibodies Market in Europe in US$ Million
by Source: A Historic Review for the Period 2009-2017
Table 81: European Monoclonal Antibodies Market Share Breakdown
by Source: 2009 VS 2019 VS 2025
Table 82: European Monoclonal Antibodies Addressable Market
Opportunity in US$ Million by Application: 2018-2025
Table 83: Monoclonal Antibodies Market in Europe: Summarization
of Historic Demand in US$ Million by Application for the Period
2009-2017
Table 84: European Monoclonal Antibodies Market Share Analysis
by Application: 2009 VS 2019 VS 2025
FRANCE
Table 85: Monoclonal Antibodies Market in France by Indication:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 86: French Monoclonal Antibodies Historic Market Scenario
in US$ Million by Indication: 2009-2017
Table 87: French Monoclonal Antibodies Market Share Analysis by
Indication: 2009 VS 2019 VS 2025
Table 88: Monoclonal Antibodies Market in France by Source:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 89: French Monoclonal Antibodies Historic Market Scenario
in US$ Million by Source: 2009-2017
Table 90: French Monoclonal Antibodies Market Share Analysis by
Source: 2009 VS 2019 VS 2025
Table 91: Monoclonal Antibodies Quantitative Demand Analysis in
France in US$ Million by Application: 2018-2025
Table 92: French Monoclonal Antibodies Historic Market Review
in US$ Million by Application: 2009-2017
Table 93: French Monoclonal Antibodies Market Share Analysis: A
17-Year Perspective by Application for 2009, 2019, and 2025
GERMANY
Table 94: Monoclonal Antibodies Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Indication for
the Period 2018-2025
Table 95: German Monoclonal Antibodies Historic Market Analysis
in US$ Million by Indication: 2009-2017
Table 96: German Monoclonal Antibodies Market Share Breakdown
by Indication: 2009 VS 2019 VS 2025
Table 97: Monoclonal Antibodies Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Source for the
Period 2018-2025
Table 98: German Monoclonal Antibodies Historic Market Analysis
in US$ Million by Source: 2009-2017
Table 99: German Monoclonal Antibodies Market Share Breakdown
by Source: 2009 VS 2019 VS 2025
Table 100: Monoclonal Antibodies Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2018-2025
Table 101: German Monoclonal Antibodies Market in Retrospect in
US$ Million by Application: 2009-2017
Table 102: Monoclonal Antibodies Market Share Distribution in
Germany by Application: 2009 VS 2019 VS 2025
ITALY
Table 103: Italian Monoclonal Antibodies Market Growth
Prospects in US$ Million by Indication for the Period 2018-2025
Table 104: Monoclonal Antibodies Historic Market Analysis in
Italy in US$ Million by Indication: 2009-2017
Table 105: Italian Monoclonal Antibodies Market by Indication:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 106: Italian Monoclonal Antibodies Market Growth
Prospects in US$ Million by Source for the Period 2018-2025
Table 107: Monoclonal Antibodies Historic Market Analysis in
Italy in US$ Million by Source: 2009-2017
Table 108: Italian Monoclonal Antibodies Market by Source:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 109: Italian Demand for Monoclonal Antibodies in US$
Million by Application: 2018 to 2025
Table 110: Monoclonal Antibodies Market Review in Italy in US$
Million by Application: 2009-2017
Table 111: Italian Monoclonal Antibodies Market Share Breakdown
by Application: 2009 VS 2019 VS 2025
UNITED KINGDOM
Table 112: United Kingdom Market for Monoclonal Antibodies:
Annual Sales Estimates and Projections in US$ Million by
Indication for the Period 2018-2025
Table 113: Monoclonal Antibodies Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Indication for the
Period 2009-2017
Table 114: United Kingdom Monoclonal Antibodies Market Share
Analysis by Indication: 2009 VS 2019 VS 2025
Table 115: United Kingdom Market for Monoclonal Antibodies:
Annual Sales Estimates and Projections in US$ Million by Source
for the Period 2018-2025
Table 116: Monoclonal Antibodies Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Source for the Period
2009-2017
Table 117: United Kingdom Monoclonal Antibodies Market Share
Analysis by Source: 2009 VS 2019 VS 2025
Table 118: United Kingdom Demand Estimates and Forecasts for
Monoclonal Antibodies in US$ Million by Application: 2018 to
2025
Table 119: United Kingdom Monoclonal Antibodies Market in US$
Million by Application: 2009-2017
Table 120: Monoclonal Antibodies Market Share Shift in the
United Kingdom by Application: 2009 VS 2019 VS 2025
SPAIN
Table 121: Spanish Monoclonal Antibodies Market Estimates and
Forecasts in US$ Million by Indication: 2018 to 2025
Table 122: Spanish Monoclonal Antibodies Historic Market Review
by Indication in US$ Million: 2009-2017
Table 123: Monoclonal Antibodies Market in Spain: Percentage
Share Breakdown of Sales by Indication for 2009, 2019, and 2025
Table 124: Spanish Monoclonal Antibodies Market Estimates and
Forecasts in US$ Million by Source: 2018 to 2025
Table 125: Spanish Monoclonal Antibodies Historic Market Review
by Source in US$ Million: 2009-2017
Table 126: Monoclonal Antibodies Market in Spain: Percentage
Share Breakdown of Sales by Source for 2009, 2019, and 2025
Table 127: Spanish Monoclonal Antibodies Market Quantitative
Demand Analysis in US$ Million by Application: 2018 to 2025
Table 128: Monoclonal Antibodies Market in Spain: Summarization
of Historic Demand Patterns in US$ Million by Application for
2009-2017
Table 129: Spanish Monoclonal Antibodies Market Share Analysis
by Application: 2009 VS 2019 VS 2025
RUSSIA
Table 130: Russian Monoclonal Antibodies Market Estimates and
Projections in US$ Million by Indication: 2018 to 2025
Table 131: Monoclonal Antibodies Market in Russia by
Indication: A Historic Review in US$ Million for 2009-2017
Table 132: Russian Monoclonal Antibodies Market Share Breakdown
by Indication: 2009 VS 2019 VS 2025
Table 133: Russian Monoclonal Antibodies Market Estimates and
Projections in US$ Million by Source: 2018 to 2025
Table 134: Monoclonal Antibodies Market in Russia by Source: A
Historic Review in US$ Million for 2009-2017
Table 135: Russian Monoclonal Antibodies Market Share Breakdown
by Source: 2009 VS 2019 VS 2025
Table 136: Russian Monoclonal Antibodies Latent Demand
Forecasts in US$ Million by Application: 2018 to 2025
Table 137: Monoclonal Antibodies Historic Demand Patterns in
Russia by Application in US$ Million for 2009-2017
Table 138: Monoclonal Antibodies Market Share Breakdown in
Russia by Application: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 139: Rest of Europe Monoclonal Antibodies Market
Estimates and Forecasts in US$ Million by Indication: 2018-2025
Table 140: Monoclonal Antibodies Market in Rest of Europe in
US$ Million by Indication: A Historic Review for the Period
2009-2017
Table 141: Rest of Europe Monoclonal Antibodies Market Share
Breakdown by Indication: 2009 VS 2019 VS 2025
Table 142: Rest of Europe Monoclonal Antibodies Market
Estimates and Forecasts in US$ Million by Source: 2018-2025
Table 143: Monoclonal Antibodies Market in Rest of Europe in
US$ Million by Source: A Historic Review for the Period
2009-2017
Table 144: Rest of Europe Monoclonal Antibodies Market Share
Breakdown by Source: 2009 VS 2019 VS 2025
Table 145: Rest of Europe Monoclonal Antibodies Addressable
Market Opportunity in US$ Million by Application: 2018-2025
Table 146: Monoclonal Antibodies Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 147: Rest of Europe Monoclonal Antibodies Market Share
Analysis by Application: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 148: Asia-Pacific Monoclonal Antibodies Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 149: Monoclonal Antibodies Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 150: Asia-Pacific Monoclonal Antibodies Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 151: Monoclonal Antibodies Market in Asia-Pacific by
Indication: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 152: Asia-Pacific Monoclonal Antibodies Historic Market
Scenario in US$ Million by Indication: 2009-2017
Table 153: Asia-Pacific Monoclonal Antibodies Market Share
Analysis by Indication: 2009 VS 2019 VS 2025
Table 154: Monoclonal Antibodies Market in Asia-Pacific by
Source: Estimates and Projections in US$ Million for the Period
2018-2025
Table 155: Asia-Pacific Monoclonal Antibodies Historic Market
Scenario in US$ Million by Source: 2009-2017
Table 156: Asia-Pacific Monoclonal Antibodies Market Share
Analysis by Source: 2009 VS 2019 VS 2025
Table 157: Monoclonal Antibodies Quantitative Demand Analysis
in Asia-Pacific in US$ Million by Application: 2018-2025
Table 158: Asia-Pacific Monoclonal Antibodies Historic Market
Review in US$ Million by Application: 2009-2017
Table 159: Asia-Pacific Monoclonal Antibodies Market Share
Analysis: A 17-Year Perspective by Application for 2009, 2019,
and 2025
AUSTRALIA
Table 160: Monoclonal Antibodies Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Indication
for the Period 2018-2025
Table 161: Australian Monoclonal Antibodies Historic Market
Analysis in US$ Million by Indication: 2009-2017
Table 162: Australian Monoclonal Antibodies Market Share
Breakdown by Indication: 2009 VS 2019 VS 2025
Table 163: Monoclonal Antibodies Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Source for
the Period 2018-2025
Table 164: Australian Monoclonal Antibodies Historic Market
Analysis in US$ Million by Source: 2009-2017
Table 165: Australian Monoclonal Antibodies Market Share
Breakdown by Source: 2009 VS 2019 VS 2025
Table 166: Monoclonal Antibodies Market in Australia: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2018-2025
Table 167: Australian Monoclonal Antibodies Market in
Retrospect in US$ Million by Application: 2009-2017
Table 168: Monoclonal Antibodies Market Share Distribution in
Australia by Application: 2009 VS 2019 VS 2025
INDIA
Table 169: Indian Monoclonal Antibodies Market Estimates and
Forecasts in US$ Million by Indication: 2018 to 2025
Table 170: Indian Monoclonal Antibodies Historic Market Review
by Indication in US$ Million: 2009-2017
Table 171: Monoclonal Antibodies Market in India: Percentage
Share Breakdown of Sales by Indication for 2009, 2019, and 2025
Table 172: Indian Monoclonal Antibodies Market Estimates and
Forecasts in US$ Million by Source: 2018 to 2025
Table 173: Indian Monoclonal Antibodies Historic Market Review
by Source in US$ Million: 2009-2017
Table 174: Monoclonal Antibodies Market in India: Percentage
Share Breakdown of Sales by Source for 2009, 2019, and 2025
Table 175: Indian Monoclonal Antibodies Market Quantitative
Demand Analysis in US$ Million by Application: 2018 to 2025
Table 176: Monoclonal Antibodies Market in India: Summarization
of Historic Demand Patterns in US$ Million by Application for
2009-2017
Table 177: Indian Monoclonal Antibodies Market Share Analysis
by Application: 2009 VS 2019 VS 2025
SOUTH KOREA
Table 178: Monoclonal Antibodies Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Indication
for the Period 2018-2025
Table 179: South Korean Monoclonal Antibodies Historic Market
Analysis in US$ Million by Indication: 2009-2017
Table 180: Monoclonal Antibodies Market Share Distribution in
South Korea by Indication: 2009 VS 2019 VS 2025
Table 181: Monoclonal Antibodies Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Source for
the Period 2018-2025
Table 182: South Korean Monoclonal Antibodies Historic Market
Analysis in US$ Million by Source: 2009-2017
Table 183: Monoclonal Antibodies Market Share Distribution in
South Korea by Source: 2009 VS 2019 VS 2025
Table 184: Monoclonal Antibodies Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Application
for the Period 2018-2025
Table 185: South Korean Monoclonal Antibodies Historic Market
Analysis in US$ Million by Application: 2009-2017
Table 186: Monoclonal Antibodies Market Share Distribution in
South Korea by Application: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 187: Rest of Asia-Pacific Market for Monoclonal
Antibodies: Annual Sales Estimates and Projections in US$
Million by Indication for the Period 2018-2025
Table 188: Monoclonal Antibodies Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by
Indication for the Period 2009-2017
Table 189: Rest of Asia-Pacific Monoclonal Antibodies Market
Share Analysis by Indication: 2009 VS 2019 VS 2025
Table 190: Rest of Asia-Pacific Market for Monoclonal
Antibodies: Annual Sales Estimates and Projections in US$
Million by Source for the Period 2018-2025
Table 191: Monoclonal Antibodies Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Source
for the Period 2009-2017
Table 192: Rest of Asia-Pacific Monoclonal Antibodies Market
Share Analysis by Source: 2009 VS 2019 VS 2025
Table 193: Rest of Asia-Pacific Demand Estimates and Forecasts
for Monoclonal Antibodies in US$ Million by Application: 2018
to 2025
Table 194: Rest of Asia-Pacific Monoclonal Antibodies Market in
US$ Million by Application: 2009-2017
Table 195: Monoclonal Antibodies Market Share Shift in Rest of
Asia-Pacific by Application: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 196: Latin American Monoclonal Antibodies Market Trends
by Region/Country in US$ Million: 2018-2025
Table 197: Monoclonal Antibodies Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 198: Latin American Monoclonal Antibodies Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 199: Latin American Monoclonal Antibodies Market Growth
Prospects in US$ Million by Indication for the Period 2018-2025
Table 200: Monoclonal Antibodies Historic Market Analysis in
Latin America in US$ Million by Indication: 2009-2017
Table 201: Latin American Monoclonal Antibodies Market by
Indication: Percentage Breakdown of Sales for 2009, 2019, and
2025
Table 202: Latin American Monoclonal Antibodies Market Growth
Prospects in US$ Million by Source for the Period 2018-2025
Table 203: Monoclonal Antibodies Historic Market Analysis in
Latin America in US$ Million by Source: 2009-2017
Table 204: Latin American Monoclonal Antibodies Market by
Source: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 205: Latin American Demand for Monoclonal Antibodies in
US$ Million by Application: 2018 to 2025
Table 206: Monoclonal Antibodies Market Review in Latin America
in US$ Million by Application: 2009-2017
Table 207: Latin American Monoclonal Antibodies Market Share
Breakdown by Application: 2009 VS 2019 VS 2025
ARGENTINA
Table 208: Argentinean Monoclonal Antibodies Market Estimates
and Forecasts in US$ Million by Indication: 2018-2025
Table 209: Monoclonal Antibodies Market in Argentina in US$
Million by Indication: A Historic Review for the Period
2009-2017
Table 210: Argentinean Monoclonal Antibodies Market Share
Breakdown by Indication: 2009 VS 2019 VS 2025
Table 211: Argentinean Monoclonal Antibodies Market Estimates
and Forecasts in US$ Million by Source: 2018-2025
Table 212: Monoclonal Antibodies Market in Argentina in US$
Million by Source: A Historic Review for the Period 2009-2017
Table 213: Argentinean Monoclonal Antibodies Market Share
Breakdown by Source: 2009 VS 2019 VS 2025
Table 214: Argentinean Monoclonal Antibodies Addressable Market
Opportunity in US$ Million by Application: 2018-2025
Table 215: Monoclonal Antibodies Market in Argentina:
Summarization of Historic Demand in US$ Million by Application
for the Period 2009-2017
Table 216: Argentinean Monoclonal Antibodies Market Share
Analysis by Application: 2009 VS 2019 VS 2025
BRAZIL
Table 217: Monoclonal Antibodies Market in Brazil by
Indication: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 218: Brazilian Monoclonal Antibodies Historic Market
Scenario in US$ Million by Indication: 2009-2017
Table 219: Brazilian Monoclonal Antibodies Market Share
Analysis by Indication: 2009 VS 2019 VS 2025
Table 220: Monoclonal Antibodies Market in Brazil by Source:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 221: Brazilian Monoclonal Antibodies Historic Market
Scenario in US$ Million by Source: 2009-2017
Table 222: Brazilian Monoclonal Antibodies Market Share
Analysis by Source: 2009 VS 2019 VS 2025
Table 223: Monoclonal Antibodies Quantitative Demand Analysis
in Brazil in US$ Million by Application: 2018-2025
Table 224: Brazilian Monoclonal Antibodies Historic Market
Review in US$ Million by Application: 2009-2017
Table 225: Brazilian Monoclonal Antibodies Market Share
Analysis: A 17-Year Perspective by Application for 2009, 2019,
and 2025
MEXICO
Table 226: Monoclonal Antibodies Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Indication for
the Period 2018-2025
Table 227: Mexican Monoclonal Antibodies Historic Market
Analysis in US$ Million by Indication: 2009-2017
Table 228: Mexican Monoclonal Antibodies Market Share Breakdown
by Indication: 2009 VS 2019 VS 2025
Table 229: Monoclonal Antibodies Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Source for the
Period 2018-2025
Table 230: Mexican Monoclonal Antibodies Historic Market
Analysis in US$ Million by Source: 2009-2017
Table 231: Mexican Monoclonal Antibodies Market Share Breakdown
by Source: 2009 VS 2019 VS 2025
Table 232: Monoclonal Antibodies Market in Mexico: Annual Sales
Estimates and Forecasts in US$ Million by Application for the
Period 2018-2025
Table 233: Mexican Monoclonal Antibodies Market in Retrospect
in US$ Million by Application: 2009-2017
Table 234: Monoclonal Antibodies Market Share Distribution in
Mexico by Application: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 235: Rest of Latin America Monoclonal Antibodies Market
Estimates and Projections in US$ Million by Indication: 2018 to
2025
Table 236: Monoclonal Antibodies Market in Rest of Latin
America by Indication: A Historic Review in US$ Million for
2009-2017
Table 237: Rest of Latin America Monoclonal Antibodies Market
Share Breakdown by Indication: 2009 VS 2019 VS 2025
Table 238: Rest of Latin America Monoclonal Antibodies Market
Estimates and Projections in US$ Million by Source: 2018 to
2025
Table 239: Monoclonal Antibodies Market in Rest of Latin
America by Source: A Historic Review in US$ Million for
2009-2017
Table 240: Rest of Latin America Monoclonal Antibodies Market
Share Breakdown by Source: 2009 VS 2019 VS 2025
Table 241: Rest of Latin America Monoclonal Antibodies Latent
Demand Forecasts in US$ Million by Application: 2018 to 2025
Table 242: Monoclonal Antibodies Historic Demand Patterns in
Rest of Latin America by Application in US$ Million for
2009-2017
Table 243: Monoclonal Antibodies Market Share Breakdown in Rest
of Latin America by Application: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 244: The Middle East Monoclonal Antibodies Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 245: Monoclonal Antibodies Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 246: The Middle East Monoclonal Antibodies Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 247: The Middle East Monoclonal Antibodies Market
Estimates and Forecasts in US$ Million by Indication: 2018 to
2025
Table 248: The Middle East Monoclonal Antibodies Historic
Market by Indication in US$ Million: 2009-2017
Table 249: Monoclonal Antibodies Market in the Middle East:
Percentage Share Breakdown of Sales by Indication for 2009,
2019, and 2025
Table 250: The Middle East Monoclonal Antibodies Market
Estimates and Forecasts in US$ Million by Source: 2018 to 2025
Table 251: The Middle East Monoclonal Antibodies Historic
Market by Source in US$ Million: 2009-2017
Table 252: Monoclonal Antibodies Market in the Middle East:
Percentage Share Breakdown of Sales by Source for 2009, 2019,
and 2025
Table 253: The Middle East Monoclonal Antibodies Market
Quantitative Demand Analysis in US$ Million by Application:
2018 to 2025
Table 254: Monoclonal Antibodies Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2009-2017
Table 255: The Middle East Monoclonal Antibodies Market Share
Analysis by Application: 2009 VS 2019 VS 2025
IRAN
Table 256: Iranian Market for Monoclonal Antibodies: Annual
Sales Estimates and Projections in US$ Million by Indication
for the Period 2018-2025
Table 257: Monoclonal Antibodies Market in Iran: Historic Sales
Analysis in US$ Million by Indication for the Period 2009-2017
Table 258: Iranian Monoclonal Antibodies Market Share Analysis
by Indication: 2009 VS 2019 VS 2025
Table 259: Iranian Market for Monoclonal Antibodies: Annual
Sales Estimates and Projections in US$ Million by Source for
the Period 2018-2025
Table 260: Monoclonal Antibodies Market in Iran: Historic Sales
Analysis in US$ Million by Source for the Period 2009-2017
Table 261: Iranian Monoclonal Antibodies Market Share Analysis
by Source: 2009 VS 2019 VS 2025
Table 262: Iranian Demand Estimates and Forecasts for
Monoclonal Antibodies in US$ Million by Application: 2018 to
2025
Table 263: Iranian Monoclonal Antibodies Market in US$ Million
by Application: 2009-2017
Table 264: Monoclonal Antibodies Market Share Shift in Iran by
Application: 2009 VS 2019 VS 2025
ISRAEL
Table 265: Israeli Monoclonal Antibodies Market Estimates and
Forecasts in US$ Million by Indication: 2018-2025
Table 266: Monoclonal Antibodies Market in Israel in US$
Please contact our Customer Support Center to get the complete Table of Contents
Download the full report: https://www.reportbuyer.com/product/5817883/?utm_source=PRN
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article